Knockout of vascular early response gene worsens chronic stroke outcomes in neonatal mice

Brain Research Bulletin

Volumn 98, Issue , 2013, Pages 111-121

  Mirza, Mehwish A ^a   Capozzi, Lori A ^a   Xu, Yan ^a   McCullough, Louise D ^a   Liu, Fudong ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Angiogenesis; Ischemic stroke; Neonate; Neurogenesis; Vascular early response gene

Indexed keywords

IMMEDIATE EARLY PROTEIN; UNCLASSIFIED DRUG; VERGE PROTEIN;

ANGIOGENESIS; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; EARLY RESPONSE GENE; GENE EXPRESSION; GLIA; HEMISPHERE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MOUSE; NERVOUS SYSTEM DEVELOPMENT; NEWBORN; NONHUMAN; OUTCOME ASSESSMENT; PERINATAL PERIOD; PRIORITY JOURNAL; PROTEIN FUNCTION; SCAR FORMATION; TISSUE REPAIR; WILD TYPE;

5-BROMO-2′-DEOXYURIDINE; ANGIOGENESIS; BRDU; CD105; CRESYL VIOLET; CV; DAPI; DIHYDROCHLORIDE; ENDOGLIN; ISCHEMIC STROKE; KNOCKOUT; KO; MCAO; MIDDLE CEREBRAL ARTERY OCCLUSION; NEONATE; NEUN; NEUROGENESIS; NEURONAL NUCLEAR ANTIGEN; P10; PAIS; PERINATAL ARTERIAL ISCHEMIC STROKE; POST-NATAL DAY 10; RICE-VANUCCI MODEL; RVM; TRIPHENYLTETRAZOLIUM CHLORIDE; TTC; VASCULAR EARLY RESPONSE GENE; VERGE; VON WILLEBRAND FACTOR; VWF; WILD-TYPE; WT;

ANIMALS; ANIMALS, NEWBORN; CICATRIX; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMEDIATE-EARLY PROTEINS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOVASCULARIZATION, PATHOLOGIC; PHOSPHOPYRUVATE HYDRATASE; STROKE; TIME FACTORS; VON WILLEBRAND FACTOR;

EID: 84883611543     PISSN: 03619230     EISSN: 18732747     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2013.07.011     Document Type: Article

References (38)

1. Bao Y., Qin L., Kim E., Bhosle S., Guo H., Febbraio M., Haskew-Layton R.E., Ratan R., Cho S. CD36 is involved in astrocyte activation and astroglial scar formation. J. Cereb. Blood Flow Metab. 2012, 32:1567-1577.
2. Bartley J., Soltau T., Wimborne H., Kim S., Martin-Studdard A., Hess D., Hill W., Waller J., Carroll J. BrdU-positive cells in the neonatal mouse hippocampus following hypoxic-ischemic brain injury. BMC Neurosci. 2005, 6:15.
3. Beck H., Semisch M., Culmsee C., Plesnila N., Hatzopoulos A.K. Egr-1 regulates expression of the glial scar component phosphacan in astrocytes after experimental stroke. Am. J. Pathol. 2008, 173:77-92.
4. Benedek A., Moricz K., Juranyi Z., Gigler G., Levay G., Harsing L.G., Matyus P., Szenasi G., Albert M. Use of TTC staining for the evaluation of tissue injury in the early phases of reperfusion after focal cerebral ischemia in rats. Brain Res. 2006, 1116:159-165.
5. Biron K.E., Dickstein D.L., Gopaul R., Jefferies W.A. Amyloid triggers extensive cerebral angiogenesis causing blood brain barrier permeability and hypervascularity in Alzheimer's disease. PLoS ONE 2011, 6:e23789.
6. Cheong J.L., Cowan F.M. Neonatal arterial ischaemic stroke: obstetric issues. Semin. Fetal Neonatal Med. 2009, 14:267-271.
7. Duff S.E., Li C., Garland J.M., Kumar S. CD105 is important for angiogenesis: evidence and potential applications. FASEB J. 2003, 17:984-992.
8. Harrison, D.E., 2011. Life span as a biomarker. The Jackson Laboratory sebsite:. http://research.jax.org/faculty/harrison/ger1vLifespan1.html.
9. Jiang X., Mu D., Biran V., Faustino J., Chang S., Rincon C.M., Sheldon R.A., Ferriero D.M. Activated Src kinases interact with the N-methyl-d-aspartate receptor after neonatal brain ischemia. Ann. Neurol. 2008, 63:632-641.
10. Jin K., Zhu Y., Sun Y., Mao X.O., Xie L., Greenberg D.A. Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:11946-11950.
11. Kahle M.P., Bix G.J. Neuronal restoration following ischemic stroke: influences, barriers, and therapeutic potential. Neurorehabil. Neural Repair 2013, 27:469-478.
12. Kleman N., Sun D., Cengiz P. Mechanisms underlying neonatal hypoxia ischemia. Open Drug Discov. J. 2010, 2:129-137.
13. Knox R., Zhao C., Miguel-Perez D., Wang S., Yuan J., Ferriero D., Jiang X. Enhanced NMDA receptor tyrosine phosphorylation and increased brain injury following neonatal hypoxia-ischemia in mice with neuronal Fyn overexpression. Neurobiol. Dis. 2013, 51:113-119.
14. Lai M.C., Yang S.N. Perinatal hypoxic-ischemic encephalopathy. J. Biomed. Biotechnol. 2011, 2011:609813.
15. Lanfranconi S., Locatelli F., Corti S., Candelise L., Comi G.P., Baron P.L., Strazzer S., Bresolin N., Bersano A. Growth factors in ischemic stroke. J. Cell. Mol. Med. 2011, 15:1645-1687.
16. Leker R.R., Toth Z.E., Shahar T., Cassiani-Ingoni R., Szalayova I., Key S., Bratincsak A., Mezey E. Transforming growth factor alpha induces angiogenesis and neurogenesis following stroke. Neuroscience 2009, 163:233-243.
17. Li X., Blizzard K.K., Zeng Z., DeVries A.C., Hurn P.D., McCullough L.D. Chronic behavioral testing after focal ischemia in the mouse: functional recovery and the effects of gender. Exp. Neurol. 2004, 187:94-104.
18. Li Y., Chen J., Zhang C.L., Wang L., Lu D., Katakowski M., Gao Q., Shen L.H., Zhang J., Lu M., et al. Gliosis and brain remodeling after treatment of stroke in rats with marrow stromal cells. Glia 2005, 49:407-417.
19. Liu F., Benashski S.E., Persky R., Xu Y., Li J., McCullough L.D. Age-related changes in AMP-activated protein kinase after stroke. Age (Dordr) 2012, 34:157-168.
20. Liu F., Benashski S.E., Xu Y., Siegel M., McCullough L.D. Effects of chronic and acute oestrogen replacement therapy in aged animals after experimental stroke. J. Neuroendocrinol. 2012, 24:319-330.
21. Liu F., Schafer D.P., McCullough L.D. TTC, fluoro-Jade B and NeuN staining confirm evolving phases of infarction induced by middle cerebral artery occlusion. J. Neurosci. Methods 2009, 179:1-8.
22. Liu F., Turtzo L.C., Li J., Regard J., Worley P., Zeevi N., McCullough L.D. Loss of vascular early response gene reduces edema formation after experimental stroke. Exp. Transl. Stroke Med. 2012, 4:12.
23. Lo E.H. Experimental models, neurovascular mechanisms and translational issues in stroke research. Br. J. Pharmacol. 2008, 153(Suppl 1):S396-S405.
24. Lo E.H. A new penumbra: transitioning from injury into repair after stroke. Nat. Med. 2008, 14:497-500.
25. Nakanishi N., Tu S., Shin Y., Cui J., Kurokawa T., Zhang D., Chen H.S., Tong G., Lipton S.A. Neuroprotection by the NR3A subunit of the NMDA receptor. J. Neurosci. 2009, 29:5260-5265.
26. Ohta M., Suzuki Y., Noda T., Ejiri Y., Dezawa M., Kataoka K., Chou H., Ishikawa N., Matsumoto N., Iwashita Y., et al. Bone marrow stromal cells infused into the cerebrospinal fluid promote functional recovery of the injured rat spinal cord with reduced cavity formation. Exp. Neurol. 2004, 187:266-278.
27. Osaka M., Honmou O., Murakami T., Nonaka T., Houkin K., Hamada H., Kocsis J.D. Intravenous administration of mesenchymal stem cells derived from bone marrow after contusive spinal cord injury improves functional outcome. Brain Res. 2010, 1343:226-235.
28. Regard J.B., Scheek S., Borbiev T., Lanahan A.A., Schneider A., Demetriades A.M., Hiemisch H., Barnes C.A., Verin A.D., Worley P.F. Verge: a novel vascular early response gene. J. Neurosci. 2004, 24:4092-4103.
29. Silver J., Miller J.H. Regeneration beyond the glial scar. Nat. Rev. Neurosci. 2004, 5:146-156.
30. Starke R.D., Ferraro F., Paschalaki K.E., Dryden N.H., McKinnon T.A., Sutton R.E., Payne E.M., Haskard D.O., Hughes A.D., Cutler D.F., et al. Endothelial von Willebrand factor regulates angiogenesis. Blood 2011, 117:1071-1080.
31. Taguchi A., Soma T., Tanaka H., Kanda T., Nishimura H., Yoshikawa H., Tsukamoto Y., Iso H., Fujimori Y., Stern D.M., et al. Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model. J. Clin. Invest. 2004, 114:330-338.
32. Tan G., Xiang X., Guo W., Zhang B., Chen W., Yang J. Study of the impact of uterine artery embolization (UAE) on endometrial microvessel density (MVD) and angiogenesis. Cardiovasc. Intervent. Radiol. 2013, 36(4):1079-1085.
33. Tureyen K., Vemuganti R., Sailor K.A., Dempsey R.J. Infarct volume quantification in mouse focal cerebral ischemia: a comparison of triphenyltetrazolium chloride and cresyl violet staining techniques. J. Neurosci. Methods 2004, 139:203-207.
34. Vannucci R.C., Perlman J.M. Interventions for perinatal hypoxic-ischemic encephalopathy. Pediatrics 1997, 100:1004-1014.
35. Wang L., Zhang Z., Wang Y., Zhang R., Chopp M. Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats. Stroke 2004, 35:1732-1737.
36. Yiu G., He Z. Glial inhibition of CNS axon regeneration. Nat. Rev. Neurosci. 2006, 7:617-627.
37. Young C.C., Brooks K.J., Buchan A.M., Szele F.G. Cellular and molecular determinants of stroke-induced changes in subventricular zone cell migration. Antioxid. Redox Signal. 2011, 14:1877-1888.
38. Zhang H., Vutskits L., Pepper M.S., Kiss J.Z. VEGF is a chemoattractant for FGF-2-stimulated neural progenitors. J. Cell Biol. 2003, 163:1375-1384.